RNA

KEI Comments Regarding NIH Exclusive License to RNAceuticals for Anti-HIV Antibodies

Posted on by Claire Cassedy

On July 27, 2020, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) regarding the “Prospective Grant of Exclusive Patent Commercialization License: N6, a Novel, Broad, Highly Potent HIV-Specific Antibody and a Broadly Neutralizing Human Anti-HIV… Continue Reading →

2019: Joint Comments on NIH Prospective License to Sixfold Biosciences on Nanoparticles Technology (and NIH Response)

Posted on by KEI Staff

(UPDATE: The NIH provided a response to our comments on January 11, 2019) On Monday January 7, 2019, KEI submitted joint comments on behalf of Health GAP, Social Security Works, the Union for Affordable Cancer Treatment, and Professor Brook Baker… Continue Reading →